▼ SELL
10b5-1 Plan
$ Value
$1.6M
Shares
3,836
Price
$419
Filed
Sep 8
Insider
Name
Cuffe Michael S.
Title
EVP and Chief Clinical Officer
CIK
0001632835
Roles
Officer
Transaction Details
Transaction Date
2025-09-08
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
31,503
Footnotes
The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2025. | Includes 2,595.9017 shares acquired under the Issuer's employee stock purchase plans. | The stock appreciation rights vested in four equal annual installments beginning on February 3, 2022.
Filing Info
Cuffe Michael S.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-10 | HCA | A | $0 |
| 2026-02-10 | HCA | F | $1.8M |
| 2026-02-03 | HCA | ▼ | $747K |
| 2026-02-03 | HCA | G | $0 |
| 2026-01-29 | HCA | A | $0 |
| 2025-09-08 | HCA | ▼ | $1.6M |
| 2025-09-04 | HCA | M | $1.9M |
| 2025-09-04 | HCA | F | $2.9M |
| 2025-09-04 | HCA | M | $0 |
Other Insiders at HCA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| FRIST THOMAS F JR | — | — | 2026-02-06 |
|
HAZEN SAMUEL N
CEO
|
— | $21.5M | 2026-02-10 |
| FRIST THOMAS F III | — | — | 2026-02-06 |
| HERCULES HOLDING II | — | — | 2026-02-06 |
| Frisco Holding II | — | — | 2026-02-06 |
| Elcan Patricia F | — | — | 2026-02-06 |
| Frist William R | — | — | 2026-02-06 |
|
Foster Jon M
EVP and COO
|
— | — | 2026-02-10 |
|
Cuffe Michael S.
EVP and Chief Clinical Officer
|
— | $747K | 2026-02-10 |
|
Wyatt Christopher F.
SVP & Controller
|
— | $2.0M | 2026-02-11 |
|
Berres Jennifer
SVP & Chief Human Res. Officer
|
— | $4.1M | 2026-02-11 |
|
McAlevey Michael R
EVP & Chief Legal & Admin Off.
|
— | $904K | 2026-02-18 |
|
Marks Mike A
EVP and CFO
|
— | — | 2026-02-10 |
|
Rossitto Erica
SVP & Chief Nurse Executive
|
— | — | 2026-02-10 |